文献速递慢性肾脏病遗传性与小管间质肾病

Mayo影像分类系统预测ADPKD肾脏结局的验证研究

Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2024-02-26

本研究在618例常染色体显性多囊肾病(ADPKD)患者中验证Mayo影像分类预测肾脏结局的能力。多数患者(82%)维持基线分类,各分类间肾脏增长和eGFR下降存在重叠,观察到的eGFR下降与预测值在1A-1D类无显著差异,但1E类显著较慢。分类可预测肾衰竭发生,但敏感性和阳性预测值有限。

要点

  • Mayo影像分类在ADPKD队列中显示可接受的稳定性,82%患者维持基线分类。
  • 观察到的eGFR下降与Mayo预测方程在1A-1D类无显著差异,1E类显著较慢。
  • 分类可预测肾衰竭,但敏感性和阳性预测值有限,个体变异大。

核心结论

  • Mayo影像分类显示出可接受的稳定性,总体可预测肾衰竭和eGFR下降速率,但各分类内疾病进展速率存在明显个体间变异。

研究设计与样本

  • 多中心ADPKD队列验证研究,纳入618例有至少1次身高调整总肾脏体积(HtTKV)测量和至少3次eGFR值且随访至少1年的患者。

主要发现

  • 平均年龄47±11岁,基线平均eGFR 64±25 ml/min per 1.73 m²。
  • 平均随访5.1±2.2年,平均总肾脏体积增长率为5.33%±3.90%/年,eGFR下降为-3.31±2.53 ml/min per 1.73 m²/年。
  • 82%患者维持基线Mayo HtTKV分类。
  • 观察到的年eGFR下降与预测值在1A、1B、1C、1D类无显著差异,但在1E类显著较慢;此现象在年龄<40岁和>60岁患者及PKD2突变者中亦观察到。
  • 允许非线性eGFR下降的多项式模型提供更准确的斜率预测。

临床怎么用

  • Mayo影像分类可用于ADPKD患者肾衰竭风险和eGFR下降速率的初步预测。
  • 临床应认识到各分类内疾病进展速率存在明显个体间变异,需结合其他指标综合评估。

局限性

  • 各分类内疾病进展速率存在明显个体间变异,分类的敏感性和阳性预测值有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Mayo Imaging Classification was developed to predict the rate of disease progression in patients with autosomal dominant polycystic kidney disease. This study aimed to validate its ability to predict kidney outcomes in a large multicenter autosomal dominant polycystic kidney disease cohort. METHODS: Included were patients with ≥1 height-adjusted total kidney volume (HtTKV) measurement and ≥3 eGFR values during ≥1-year follow-up. Mayo HtTKV class stability, kidney growth rates, and eGFR decline rates were calculated. The observed eGFR decline was compared with predictions from the Mayo Clinic future eGFR equation. The future eGFR prediction equation was also tested for nonlinear eGFR decline. Kaplan-Meier survival analysis and Cox regression models were used to assess time to kidney failure using Mayo HtTKV class as a predictor variable. RESULTS: We analyzed 618 patients with a mean age of 47±11 years and mean eGFR of 64±25 ml/min per 1.73 m 2 at baseline. Most patients (82%) remained in their baseline Mayo HtTKV class. During a mean follow-up of 5.1±2.2 years, the mean total kidney volume growth rates and eGFR decline were 5.33%±3.90%/yr and -3.31±2.53 ml/min per 1.73 m 2 per year, respectively. Kidney growth and eGFR decline showed considerable overlap between the classes. The observed annual eGFR decline was not significantly different from the predicted values for classes 1A, 1B, 1C, and 1D but significantly slower for class 1E. This was also observed in patients aged younger than 40 years and older than 60 years and those with PKD2 mutations. A polynomial model allowing nonlinear eGFR decline provided more accurate slope predictions. Ninety-seven patients (16%) developed kidney failure during follow-up. The classification predicted the development of kidney failure, although the sensitivity and positive predictive values were limited. CONCLUSIONS: The Mayo Imaging Classification demonstrated acceptable stability and generally predicted kidney failure and eGFR decline rate. However, there was marked interindividual variability in the rate of disease progression within each class.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Bais T, Geertsema P, Knol MGE, et al. Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD. Clin J Am Soc Nephrol. 2024. PMID: 38407866. doi:10.2215/CJN.0000000000000427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。